US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dianthus Therapeutics Inc.

37.15

+1.584.44%

Volume:1.94M

Turnover:69.34M

Market Cap:1.20B

PE:-11.43

High:37.42

Open:33.80

Low:33.50

Close:35.57

52wk High:37.42

52wk Low:13.37

Shares:32.19M

Float Shares:13.46M

Volume Ratio:1.17

T/O Rate:14.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2490

EPS(LYR):-2.5506

ROE:-34.71%

ROA:-23.37%

PB:3.95

PE(LYR):-14.57

Loading ...

Overview Company News Filings

Dianthus Therapeutics (DNTH) Gets a Buy from Guggenheim

Dianthus Therapeutics Is Maintained at Outperform by Wedbush

Wedbush Raises Price Target on Dianthus Therapeutics to $42 From $34, Keeps Outperform Rating

MT Newswires Live

Oncology Institute Inc: Richard Barasch Will Retire From His Role as Chairman

THOMSON REUTERS

the Oncology Institute Announces Changes to Board of Directors

THOMSON REUTERS

Stock Track | Dianthus Therapeutics Soars 5.11% as Evercore ISI Maintains Buy Rating

Stock Track | Dianthus Therapeutics Plummets 5.33% as Q2 Earnings Miss Estimates

Stock Track | Dianthus Therapeutics Soars 6.06% Pre-Market Despite Mixed Q2 Earnings, Buoyed by Analyst Optimism

Stock Track | Dianthus Therapeutics (DNTH) Soars 6.06% Following Q2 Earnings Report and Strong Analyst Outlook

Dianthus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Dianthus Therapeutics Q2 EPS $(0.88) Misses $(0.86) Estimate, Sales $193.00K Miss $1.01M Estimate

Dianthus Therapeutics Inc - $309.1 Mln Cash Runway Into 2H'27

THOMSON REUTERS

Dianthus Therapeutics Inc - Phase 3 Captivate Trial of Claseprubart in Cidp Ongoing; Interim Analysis Expected 2H'26

THOMSON REUTERS

Press Release: Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial Results

Dianthus Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview

BUZZ-U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos Financial

William Blair Initiates Dianthus Therapeutics at Outperform

MT Newswires Live

Dianthus Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Simon Read

Press Release: Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors

Dianthus Therapeutics Inc. Appoints Simon Read, Ph.D., to Board as Leon O. Moulder, Jr. Resigns

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DNTH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DNTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNTH\",,,,,undefined,":{"symbol":"DNTH","market":"US","secType":"STK","nameCN":"Dianthus Therapeutics Inc.","latestPrice":37.15,"timestamp":1757531636035,"preClose":35.57,"halted":0,"volume":1939508,"delay":0,"floatShares":13459144,"shares":32188345,"eps":-3.249007,"marketStatus":"Trading","change":1.58,"latestTime":"09-10 15:13:57 EDT","open":33.8,"high":37.42,"low":33.4979,"amount":69337663.13604,"amplitude":0.110264,"askPrice":37.24,"askSize":15,"bidPrice":37.18,"bidSize":92,"shortable":3,"etf":0,"ttmEps":-3.249007,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1757534400000},"marketStatusCode":2,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":35.57,"preHourTrading":{"tag":"盘前","latestPrice":33.79,"preClose":35.57,"latestTime":"09:29 EDT","volume":67218,"amount":2404566.32379,"timestamp":1757510968068},"postHourTrading":{"tag":"盘后","latestPrice":35.7,"preClose":35.57,"latestTime":"19:59 EDT","volume":46425,"amount":1651865.4842,"timestamp":1757462343032},"volumeRatio":1.168579,"impliedVol":0.6415,"impliedVolPercentile":0.436},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNTH\",,,,,undefined,":{"symbol":"DNTH","floatShares":13459144,"roa":"-23.37%","roe":"-34.71%","lyrEps":-2.55056,"volumeRatio":1.168579,"shares":32188345,"dividePrice":0,"high":37.42,"amplitude":0.110264,"preClose":35.57,"low":33.4979,"week52Low":13.365,"pbRate":"3.95","psRate":"246.35","week52High":37.42,"institutionHeld":0,"latestPrice":37.15,"committee":0.719626,"eps":-3.249007,"divideRate":0,"volume":1939508,"delay":0,"ttmEps":-3.249007,"open":33.8,"prevYearClose":21.8,"prevWeekClose":26.5,"prevMonthClose":23.57,"prevQuarterClose":18.63,"fiveDayClose":24.26,"twentyDayClose":19.9,"sixtyDayClose":18.31},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DNTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-07","symbol":"DNTH","fiscalQuarterEnding":"2025/06","expectedEps":-0.86,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.88},{"market":"US","date":"2025-05-12","symbol":"DNTH","fiscalQuarterEnding":"2025/03","expectedEps":-0.86,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.82},{"market":"US","date":"2025-03-11","symbol":"DNTH","fiscalQuarterEnding":"2024/12","expectedEps":-0.85,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2024-11-07","symbol":"DNTH","fiscalQuarterEnding":"2024/09","expectedEps":-0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.74},{"market":"US","date":"2024-08-08","symbol":"DNTH","fiscalQuarterEnding":"2024/06","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DNTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DNTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5385,"buy":0.4615,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5385,"analysts":13,"updateTime":1751515200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DNTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DNTH","date":"2025-09-09","current":-8.919858,"percent":0.537313,"low":-21.520733,"twenty":-14.830195,"median":-9.797719,"eighty":-5.774826,"high":-2.378652,"avg":-10.190222,"sd":4.58644,"marketCap":1023589371},"quantilePoints":[{"date":"2023-09-22","current":-6.821887,"twenty":-6.869759,"median":-6.842701,"eighty":-6.807317,"marketCap":194260047},{"date":"2023-09-29","current":-5.576152,"twenty":-6.838538,"median":-5.576152,"eighty":-5.435929,"marketCap":201460812},{"date":"2023-10-06","current":-4.920135,"twenty":-6.800032,"median":-5.4757,"eighty":-5.354747,"marketCap":177759540},{"date":"2023-10-13","current":-4.916034,"twenty":-6.077097,"median":-5.403948,"eighty":-4.942276,"marketCap":177611407},{"date":"2023-10-20","current":-5.11694,"twenty":-5.587632,"median":-5.309646,"eighty":-5.016077,"marketCap":184869921},{"date":"2023-10-27","current":-4.75613,"twenty":-5.576152,"median":-5.262494,"eighty":-4.957036,"marketCap":171834222},{"date":"2023-11-03","current":-4.920135,"twenty":-5.49415,"median":-5.12514,"eighty":-4.920135,"marketCap":177759540},{"date":"2023-11-10","current":-4.678228,"twenty":-5.457249,"median":-5.084139,"eighty":-4.879133,"marketCap":169019695},{"date":"2023-11-17","current":-3.935775,"twenty":-5.444949,"median":-4.957036,"eighty":-4.76023,"marketCap":169663374},{"date":"2023-11-24","current":-4.021709,"twenty":-5.412148,"median":-4.920135,"eighty":-4.674948,"marketCap":173367815},{"date":"2023-12-01","current":-3.842966,"twenty":-5.377707,"median":-4.920135,"eighty":-3.993522,"marketCap":165662579},{"date":"2023-12-08","current":-3.640162,"twenty":-5.338346,"median":-4.907834,"eighty":-3.949524,"marketCap":156920099},{"date":"2023-12-15","current":-2.684576,"twenty":-5.297345,"median":-4.846332,"eighty":-3.884902,"marketCap":115726721},{"date":"2023-12-22","current":-3.007688,"twenty":-5.267824,"median":-4.788931,"eighty":-3.85534,"marketCap":129655417},{"date":"2023-12-29","current":-3.482043,"twenty":-5.235843,"median":-4.75818,"eighty":-3.842966,"marketCap":150103929},{"date":"2024-01-05","current":-4.482315,"twenty":-5.235843,"median":-4.715129,"eighty":-3.861528,"marketCap":193223616},{"date":"2024-01-12","current":-4.05952,"twenty":-5.169421,"median":-4.670027,"eighty":-3.873902,"marketCap":174997769},{"date":"2024-01-19","current":-3.952961,"twenty":-5.12186,"median":-4.521845,"eighty":-3.879402,"marketCap":170404263},{"date":"2024-01-26","current":-6.135656,"twenty":-5.267824,"median":-4.661827,"eighty":-3.893152,"marketCap":264495873},{"date":"2024-02-02","current":-14.091886,"twenty":-5.428549,"median":-4.735629,"eighty":-3.901401,"marketCap":607473021},{"date":"2024-02-09","current":-15.77856,"twenty":-5.593373,"median":-4.788931,"eighty":-3.913775,"marketCap":680182147},{"date":"2024-02-16","current":-16.247836,"twenty":-6.141843,"median":-4.875033,"eighty":-3.933712,"marketCap":700411702},{"date":"2024-02-23","current":-16.322648,"twenty":-6.585949,"median":-4.911934,"eighty":-3.935775,"marketCap":703636704},{"date":"2024-03-01","current":-16.832731,"twenty":-6.855189,"median":-4.920135,"eighty":-3.939212,"marketCap":725625351},{"date":"2024-03-08","current":-17.220393,"twenty":-14.108208,"median":-4.920135,"eighty":-3.952961,"marketCap":742336722},{"date":"2024-03-15","current":-18.274564,"twenty":-15.869694,"median":-5.055438,"eighty":-3.952961,"marketCap":787779926},{"date":"2024-03-22","current":-19.002283,"twenty":-16.27504,"median":-5.103895,"eighty":-3.958461,"marketCap":819150396},{"date":"2024-03-28","current":-20.617859,"twenty":-16.390659,"median":-5.12104,"eighty":-3.98046,"marketCap":898010856},{"date":"2024-04-05","current":-16.662734,"twenty":-16.662734,"median":-5.235843,"eighty":-3.987335,"marketCap":725745374},{"date":"2024-04-12","current":-16.777278,"twenty":-16.777278,"median":-5.350646,"eighty":-3.990772,"marketCap":730734324},{"date":"2024-04-19","current":-15.922581,"twenty":-16.832731,"median":-5.444949,"eighty":-3.99421,"marketCap":693508032},{"date":"2024-04-26","current":-14.143673,"twenty":-16.777278,"median":-5.535151,"eighty":-4.021709,"marketCap":616027659},{"date":"2024-05-03","current":-16.178636,"twenty":-16.662734,"median":-5.637242,"eighty":-4.021709,"marketCap":704660510},{"date":"2024-05-10","current":-14.570862,"twenty":-16.662734,"median":-6.140812,"eighty":-4.049207,"marketCap":731661246},{"date":"2024-05-17","current":-15.342363,"twenty":-16.621896,"median":-6.530951,"eighty":-4.05952,"marketCap":770401432},{"date":"2024-05-24","current":-12.724299,"twenty":-16.45867,"median":-6.737265,"eighty":-4.100768,"marketCap":638937940},{"date":"2024-05-31","current":-12.098897,"twenty":-16.404261,"median":-6.842701,"eighty":-4.106268,"marketCap":607534008},{"date":"2024-06-07","current":-12.233329,"twenty":-16.390659,"median":-12.098897,"eighty":-4.121392,"marketCap":614284386},{"date":"2024-06-14","current":-15.75779,"twenty":-16.354335,"median":-12.233329,"eighty":-4.176389,"marketCap":791261684},{"date":"2024-06-21","current":-15.114854,"twenty":-16.327131,"median":-12.630781,"eighty":-4.296009,"marketCap":758977268},{"date":"2024-06-28","current":-14.565435,"twenty":-16.324142,"median":-12.706764,"eighty":-4.381256,"marketCap":731388767},{"date":"2024-07-05","current":-15.459702,"twenty":-16.325636,"median":-12.794437,"eighty":-4.452753,"marketCap":776293455},{"date":"2024-07-12","current":-16.932611,"twenty":-16.417863,"median":-13.066224,"eighty":-4.47819,"marketCap":850254116},{"date":"2024-07-15","current":-16.920921,"twenty":-16.466954,"median":-13.180199,"eighty":-4.480252,"marketCap":849667127},{"date":"2024-08-02","current":-16.371502,"twenty":-16.45867,"median":-13.180199,"eighty":-4.482315,"marketCap":822078626},{"date":"2024-08-09","current":-13.845994,"twenty":-16.50009,"median":-13.738229,"eighty":-4.561374,"marketCap":784804801},{"date":"2024-08-16","current":-15.438194,"twenty":-16.45867,"median":-13.792112,"eighty":-4.661827,"marketCap":875052279},{"date":"2024-08-23","current":-14.304023,"twenty":-16.390659,"median":-14.112289,"eighty":-4.678228,"marketCap":810766318},{"date":"2024-08-30","current":-14.899592,"twenty":-16.390659,"median":-14.219338,"eighty":-4.715129,"marketCap":844523786},{"date":"2024-09-06","current":-14.490462,"twenty":-16.375333,"median":-14.311791,"eighty":-4.74793,"marketCap":821333873},{"date":"2024-09-13","current":-14.402421,"twenty":-16.338396,"median":-14.319559,"eighty":-4.75941,"marketCap":816343639},{"date":"2024-09-20","current":-14.552608,"twenty":-16.324142,"median":-14.311791,"eighty":-4.783191,"marketCap":824856392},{"date":"2024-09-27","current":-13.993291,"twenty":-16.306326,"median":-14.304023,"eighty":-4.815172,"marketCap":793153726},{"date":"2024-10-04","current":-14.221161,"twenty":-16.285922,"median":-14.291076,"eighty":-4.861093,"marketCap":806069627},{"date":"2024-10-11","current":-14.672555,"twenty":-16.269355,"median":-14.319559,"eighty":-4.877493,"marketCap":831655088},{"date":"2024-10-18","current":-14.522306,"twenty":-16.254626,"median":-14.311791,"eighty":-4.902094,"marketCap":823138846},{"date":"2024-10-25","current":-14.475677,"twenty":-16.248614,"median":-14.360865,"eighty":-4.914394,"marketCap":820495874},{"date":"2024-10-31","current":-14.486039,"twenty":-16.239675,"median":-14.366036,"eighty":-4.918495,"marketCap":821083201},{"date":"2024-11-08","current":-13.087312,"twenty":-16.213004,"median":-14.381745,"eighty":-4.920135,"marketCap":878053924},{"date":"2024-11-15","current":-11.244659,"twenty":-16.189942,"median":-14.360865,"eighty":-4.920135,"marketCap":754426637},{"date":"2024-11-22","current":-8.941908,"twenty":-16.180782,"median":-14.311791,"eighty":-4.920135,"marketCap":599930480},{"date":"2024-11-29","current":-10.582949,"twenty":-16.17095,"median":-14.273283,"eighty":-4.920135,"marketCap":710031190},{"date":"2024-12-06","current":-10.437372,"twenty":-16.142849,"median":-14.241876,"eighty":-4.934895,"marketCap":700264191},{"date":"2024-12-13","current":-10.36679,"twenty":-16.097823,"median":-14.188265,"eighty":-4.996397,"marketCap":695528677},{"date":"2024-12-20","current":-10.163866,"twenty":-16.05809,"median":-14.112289,"eighty":-5.061998,"marketCap":681914073},{"date":"2024-12-27","current":-10.14622,"twenty":-16.019613,"median":-14.091886,"eighty":-5.076759,"marketCap":680730195},{"date":"2025-01-03","current":-10.234448,"twenty":-15.922581,"median":-13.957579,"eighty":-5.096439,"marketCap":686649588},{"date":"2025-01-10","current":-11.284361,"twenty":-15.89482,"median":-13.822388,"eighty":-5.108369,"marketCap":757090364},{"date":"2025-01-17","current":-8.474299,"twenty":-15.887478,"median":-13.728741,"eighty":-5.115822,"marketCap":568557697},{"date":"2025-01-24","current":-9.828599,"twenty":-15.834329,"median":-13.708453,"eighty":-5.12186,"marketCap":659420380},{"date":"2025-01-31","current":-9.603618,"twenty":-15.788231,"median":-13.553088,"eighty":-5.191562,"marketCap":644325928},{"date":"2025-02-07","current":-10.128574,"twenty":-15.779567,"median":-13.462457,"eighty":-5.235843,"marketCap":679546316},{"date":"2025-02-14","current":-10.644708,"twenty":-15.766098,"median":-13.180199,"eighty":-5.267824,"marketCap":714174765},{"date":"2025-02-21","current":-10.455018,"twenty":-15.745542,"median":-13.087312,"eighty":-5.305545,"marketCap":701448070},{"date":"2025-02-28","current":-9.285997,"twenty":-15.702913,"median":-12.81575,"eighty":-5.346546,"marketCap":623016113},{"date":"2025-03-07","current":-10.375613,"twenty":-15.663831,"median":-12.724299,"eighty":-5.384267,"marketCap":696120616},{"date":"2025-03-14","current":-8.045567,"twenty":-15.60664,"median":-12.588406,"eighty":-5.420348,"marketCap":683623809},{"date":"2025-03-21","current":-7.727979,"twenty":-15.500032,"median":-12.233329,"eighty":-5.449869,"marketCap":656638658},{"date":"2025-03-28","current":-7.512473,"twenty":-15.459702,"median":-12.013661,"eighty":-5.472009,"marketCap":638327306},{"date":"2025-04-04","current":-6.416037,"twenty":-15.451099,"median":-11.624039,"eighty":-5.526951,"marketCap":545164287},{"date":"2025-04-11","current":-5.898066,"twenty":-15.431979,"median":-11.290978,"eighty":-5.587632,"marketCap":501152792},{"date":"2025-04-17","current":-7.175981,"twenty":-15.413286,"median":-11.262304,"eighty":-5.60754,"marketCap":609735897},{"date":"2025-04-25","current":-8.026663,"twenty":-15.369114,"median":-11.0285,"eighty":-5.622077,"marketCap":682017550},{"date":"2025-05-02","current":-8.204554,"twenty":-15.321347,"median":-10.898364,"eighty":-5.689407,"marketCap":697132746},{"date":"2025-05-09","current":-7.796217,"twenty":-15.230244,"median":-10.759405,"eighty":-5.898822,"marketCap":662436738},{"date":"2025-05-16","current":-5.986178,"twenty":-15.201008,"median":-10.704262,"eighty":-5.916298,"marketCap":602999662},{"date":"2025-05-23","current":-5.861665,"twenty":-15.193619,"median":-10.675588,"eighty":-5.916298,"marketCap":590457269},{"date":"2025-05-30","current":-5.698841,"twenty":-15.181369,"median":-10.600594,"eighty":-5.861665,"marketCap":574055678},{"date":"2025-06-06","current":-5.92871,"twenty":-15.126544,"median":-10.582949,"eighty":-5.698841,"marketCap":597210865},{"date":"2025-06-13","current":-6.15858,"twenty":-15.114854,"median":-10.503543,"eighty":-5.724382,"marketCap":620366052},{"date":"2025-06-20","current":-5.567944,"twenty":-15.086799,"median":-10.455018,"eighty":-5.687986,"marketCap":560870086},{"date":"2025-06-27","current":-5.788235,"twenty":-15.056571,"median":-10.424138,"eighty":-5.643102,"marketCap":583060473},{"date":"2025-07-03","current":-6.018104,"twenty":-15.025316,"median":-10.371201,"eighty":-5.641637,"marketCap":606215660},{"date":"2025-07-11","current":-6.580007,"twenty":-15.002134,"median":-10.30503,"eighty":-5.677131,"marketCap":662817229},{"date":"2025-07-18","current":-6.496998,"twenty":-14.98745,"median":-10.28959,"eighty":-5.714166,"marketCap":654455633},{"date":"2025-07-25","current":-6.956737,"twenty":-14.950568,"median":-10.234448,"eighty":-5.730129,"marketCap":700766007},{"date":"2025-08-01","current":-6.599162,"twenty":-14.912021,"median":-10.163866,"eighty":-5.73396,"marketCap":664746827},{"date":"2025-08-08","current":-6.113883,"twenty":-14.897039,"median":-10.14622,"eighty":-5.764609,"marketCap":615863655},{"date":"2025-08-15","current":-5.680098,"twenty":-14.891675,"median":-10.102106,"eighty":-5.714166,"marketCap":651813986},{"date":"2025-08-22","current":-6.633794,"twenty":-14.884329,"median":-10.031524,"eighty":-5.730129,"marketCap":761254359},{"date":"2025-08-29","current":-6.959172,"twenty":-14.857999,"median":-9.84404,"eighty":-5.73396,"marketCap":798592839},{"date":"2025-09-05","current":-6.917097,"twenty":-14.83641,"median":-9.826394,"eighty":-5.754393,"marketCap":793764587},{"date":"2025-09-09","current":-8.919858,"twenty":-14.830195,"median":-9.797719,"eighty":-5.774826,"marketCap":1023589371}],"updateTime":1757503226326},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DNTH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2565459605","title":"Dianthus Therapeutics (DNTH) Gets a Buy from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2565459605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565459605?lang=en_us&edition=fundamental","pubTime":"2025-09-06 05:45","pubTimestamp":1757108709,"startTime":"0","endTime":"0","summary":"In a report released today, Yatin Suneja from Guggenheim reiterated a Buy rating on Dianthus Therapeutics, with a price target of $92.00. The compa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/dianthus-therapeutics-dnth-gets-a-buy-from-guggenheim-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/dianthus-therapeutics-dnth-gets-a-buy-from-guggenheim-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2561951604","title":"Dianthus Therapeutics Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2561951604","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561951604?lang=en_us&edition=fundamental","pubTime":"2025-08-21 21:41","pubTimestamp":1755783660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DNTH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 21, 2025 09:41 ET (13:41 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","DNTH"],"gpt_icon":0},{"id":"2561346921","title":"Wedbush Raises Price Target on Dianthus Therapeutics to $42 From $34, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2561346921","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561346921?lang=en_us&edition=fundamental","pubTime":"2025-08-21 18:53","pubTimestamp":1755773627,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics (DNTH) has an average rating of buy and mean price target of $51.78, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DNTH","LENZ"],"gpt_icon":0},{"id":"2559498966","title":"Oncology Institute Inc: Richard Barasch Will Retire From His Role as Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2559498966","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559498966?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:04","pubTimestamp":1755115440,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nTUA2MWPKG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOI","BK4185","BK4139","DNTH"],"gpt_icon":0},{"id":"2559298965","title":"the Oncology Institute Announces Changes to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2559298965","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559298965?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:04","pubTimestamp":1755115440,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nTUA2MWPKG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DNTH","TOI","TOIIW","BK4185"],"gpt_icon":0},{"id":"1197688629","title":"Stock Track | Dianthus Therapeutics Soars 5.11% as Evercore ISI Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1197688629","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197688629?lang=en_us&edition=fundamental","pubTime":"2025-08-12 22:08","pubTimestamp":1755007736,"startTime":"0","endTime":"0","summary":"Shares of Dianthus Therapeutics Inc. (DNTH) are soaring 5.11% in Tuesday's pre-market trading session, following a positive analyst report from Evercore ISI. The biotech company's stock has caught...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DNTH"],"gpt_icon":0},{"id":"1196002518","title":"Stock Track | Dianthus Therapeutics Plummets 5.33% as Q2 Earnings Miss Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=1196002518","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196002518?lang=en_us&edition=fundamental","pubTime":"2025-08-08 22:50","pubTimestamp":1754664615,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc. (DNTH) saw its stock price plummet 5.33% in pre-market trading on Friday following the release of its second-quarter earnings report. The biotech company's financial...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DNTH"],"gpt_icon":0},{"id":"1128059491","title":"Stock Track | Dianthus Therapeutics Soars 6.06% Pre-Market Despite Mixed Q2 Earnings, Buoyed by Analyst Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=1128059491","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128059491?lang=en_us&edition=fundamental","pubTime":"2025-08-08 21:33","pubTimestamp":1754659985,"startTime":"0","endTime":"0","summary":"Shares of Dianthus Therapeutics Inc (DNTH) are soaring 6.06% in pre-market trading on Friday, despite reporting mixed second-quarter results. The biotechnology company's stock movement comes on the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DNTH"],"gpt_icon":0},{"id":"1151064535","title":"Stock Track | Dianthus Therapeutics (DNTH) Soars 6.06% Following Q2 Earnings Report and Strong Analyst Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1151064535","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151064535?lang=en_us&edition=fundamental","pubTime":"2025-08-08 21:32","pubTimestamp":1754659965,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc. (DNTH) stock is soaring 6.06% in pre-market trading on Friday, following the release of its second-quarter earnings report. Despite slightly missing analyst expectations,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DNTH"],"gpt_icon":0},{"id":"2557519737","title":"Dianthus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2557519737","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557519737?lang=en_us&edition=fundamental","pubTime":"2025-08-08 11:20","pubTimestamp":1754623223,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryDianthus Therapeutics Inc DNTH.OQ reported a quarterly adjusted loss of 88 cents per share for the quarter end","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U008T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH"],"gpt_icon":0},{"id":"2557599764","title":"Dianthus Therapeutics Q2 EPS $(0.88) Misses $(0.86) Estimate, Sales $193.00K Miss $1.01M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557599764","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557599764?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:45","pubTimestamp":1754599509,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Q2 EPS $(0.88) Misses $(0.86) Estimate, Sales $193.00K Miss $1.01M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46981913/dianthus-therapeutics-q2-eps-0-88-misses-0-86-estimate-sales-193-00k-miss-1-01m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","LENZ"],"gpt_icon":0},{"id":"2557912655","title":"Dianthus Therapeutics Inc - $309.1 Mln Cash Runway Into 2H'27","url":"https://stock-news.laohu8.com/highlight/detail?id=2557912655","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557912655?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:01","pubTimestamp":1754596863,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nTUABMNWWD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2557242591","title":"Dianthus Therapeutics Inc - Phase 3 Captivate Trial of Claseprubart in Cidp Ongoing; Interim Analysis Expected 2H'26","url":"https://stock-news.laohu8.com/highlight/detail?id=2557242591","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557242591?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:01","pubTimestamp":1754596863,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nTUABMNWWD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2557159517","title":"Press Release: Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2557159517","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557159517?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:01","pubTimestamp":1754596860,"startTime":"0","endTime":"0","summary":"Phase 2 MaGic trial of claseprubart  in generalized Myasthenia Gravis  top-line results anticipated in September 2025; the first of three catalysts for the claseprubart neuromuscular franchise by YE'26. Phase 3 CAPTIVATE trial of claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy  ongoing; interim responder analysis anticipated in 2H'26. Phase 2 MoMeNtum trial of claseprubart in Multifocal Motor Neuropathy  ongoing;NEW YORK and WALTHAM, Mass., Aug. 07, 2025  -- Dianthus Therapeutics, Inc. , a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today reported financial results for the second quarter ending June 30, 2025, and provided an update on recent business achievements.Claseprubart is an investigational, clinical-stage, potent monoclonal antibody engineered to selectively target the classical pathway by inhibiting only the active form of the C1s protein, a clinically","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0267386448.USD","IE00BKVL7J92.USD","CMC","LENZ","LU2746668974.SGD","LU0149725797.USD","DNTH","LU0170899867.USD","LU0882574139.USD","IE00BFXG1179.USD","IE00BHPRN162.USD","INN","LU1363072403.SGD","BK4007","LU0971096721.USD","BK4181","BK4218","IE00BZ1G4Q59.USD","BK4539","BK4006","BK4139","LU2746668461.USD","IE00B1BXHZ80.USD"],"gpt_icon":0},{"id":"2557337641","title":"Dianthus Therapeutics Inc  expected to post a loss of 87 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557337641","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557337641?lang=en_us&edition=fundamental","pubTime":"2025-08-05 07:12","pubTimestamp":1754349139,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc  expected to post a loss of87cents a share - Earnings Preview Dianthus Therapeutics Inc DNTH.OQ DNTH.O is expected to  show a fall in quarterly revenue when it reports  resul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nL8N3TW2WY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH"],"gpt_icon":0},{"id":"2548141158","title":"BUZZ-U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2548141158","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548141158?lang=en_us&edition=fundamental","pubTime":"2025-07-03 02:00","pubTimestamp":1751479228,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos FinancialEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nL6N3SZ0DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAVA","NUE","RIVN","AVBP","VFC","KBR","CNC","ELV","MO","ISTR","DNTH","APA","STZ","ANF","XOM","ABM","FCX","OGN","FSLR","REGN","GEV","BMRC","UAA","ALV","CVX","VRNT","ABEO","GBX","AX","DFDV","SPOT","OMDA","CARG","STLD","SCCO","ROST","PRMB","EQT","ZVRA","CVNA","JBL"],"gpt_icon":1},{"id":"2548899565","title":"William Blair Initiates Dianthus Therapeutics at Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2548899565","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548899565?lang=en_us&edition=fundamental","pubTime":"2025-07-02 19:26","pubTimestamp":1751455561,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics (DNTH) has an average rating of buy and mean price target of $51.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DNTH","LENZ"],"gpt_icon":0},{"id":"2537927362","title":"Dianthus Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Simon Read","url":"https://stock-news.laohu8.com/highlight/detail?id=2537927362","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537927362?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:40","pubTimestamp":1747946429,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing identifies Simon Read as a beneficial owner in the role of Director. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL67sqY0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2537592284","title":"Press Release: Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2537592284","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537592284?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:10","pubTimestamp":1747944600,"startTime":"0","endTime":"0","summary":"Dr. Read brings >30 years of leadership and scientific expertise in the biopharmaceutical industry. Previously served as CEO and Founder of Mariana Oncology until its acquisition by Novartis in 2024 and CSO of Ra Pharma until its acquisition by UCB in 2020. NEW YORK and WALTHAM, Mass., May 22, 2025  -- Dianthus Therapeutics, Inc. , a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the appointment of Simon Read, Ph.D., to the Company's Board of Directors. Dr. Read is a serial entrepreneur with more than 30 years of biopharmaceutical experience. Dianthus also announced that Lonnie Moulder will transition from the Board of Directors.\"The Dianthus team has done an excellent job executing rapidly on its three clinical programs with DNTH103,\" said Dr. Read. \"This is an exciting time for the Company with Phase 2 MaGic results anticipated in September. I look forward to part","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4232","BK4139","LENZ","BK4022","UK","R","BK4233","BK4539","BK4528","BK4205","DNTH"],"gpt_icon":0},{"id":"2537924032","title":"Dianthus Therapeutics Inc. Appoints Simon Read, Ph.D., to Board as Leon O. Moulder, Jr. Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2537924032","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537924032?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:06","pubTimestamp":1747944406,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc. has announced a change in its Board of Directors. Leon O. Moulder, Jr. has resigned from the board, while Simon Read, Ph.D., has been appointed as a Class III director. Dr. Read will also serve as a member of the Science and Technology Committee and the Nominating and Corporate Governance Committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDLbQBWM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":42,"code":"91000000","status":"200"}]}}